What: The MIT Enterprise Forum of Cambridge will host a case
presentation by John Danner, president and CEO of Codon Devices, a
privately held biotechnology company focused on enabling commercial
applications of synthetic biology. Codon Devices' proprietary
BioFAB(TM) production platform is expected to enable large-scale
biological research, engineered cells that produce novel
pharmaceuticals, improved vaccines, agricultural products and
biorefineries for the production of industrial chemicals and energy.
